This inventor holds 1 USPTO granted patent. Top assignee: Schwarz Pharma Ag. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Gai Ling Li: Innovator in Iontophoretic Drug Delivery
Introduction
Gai Ling Li is a notable inventor based in Middlesex, GB. He has made significant contributions to the field of drug delivery systems, particularly in the treatment of Parkinson's disease. His innovative approach has led to advancements in the efficacy of medication delivery.
Latest Patents
Gai Ling Li holds a patent for the "Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease." This patent describes a composition that includes rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol/l, with a pH of 4 to 6.5. The invention utilizes an iontophoretic device, which allows for a higher flux of rotigotine across the human stratum corneum compared to conventional passive diffusion systems. This advancement has the potential to improve treatment outcomes for patients suffering from Parkinson's disease.
Career Highlights
Gai Ling Li is associated with Schwarz Pharma AG, where he continues to work on innovative drug delivery solutions. His research and development efforts have positioned him as a key figure in the pharmaceutical industry, particularly in the area of transdermal drug delivery.
Collaborations
Gai Ling Li has collaborated with notable colleagues, including Johanna Aaltje Bouwstra and Hans-Michael Wolff. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic strategies.
Conclusion
Gai Ling Li's contributions to the field of drug delivery, particularly through his patent on iontophoretic delivery systems, highlight his role as an innovator in the pharmaceutical industry. His work continues to pave the way for improved treatment options for patients with Parkinson's disease.